These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 35196994)

  • 1. Serum homocysteine is associated with tubular interstitial lesions at the early stage of IgA nephropathy.
    Li Z; Han Q; Ye H; Li J; Wei X; Zhang R; Huang Q; Xu Y; Liu G; Li B; Yang Q
    BMC Nephrol; 2022 Feb; 23(1):78. PubMed ID: 35196994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homocysteine and IgA nephropathy: observational and Mendelian randomization analyses.
    Zhang YM; Zhou XJ; Shi SF; Liu LJ; Lyu JC; Zhang H
    Chin Med J (Engl); 2020 Feb; 133(3):277-284. PubMed ID: 31929371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between blood neutrophil-lymphocyte ratio and renal tubular atrophy/interstitial fibrosis in IgA nephropathy patients.
    Chai L; Cai K; Wang K; Luo Q
    J Clin Lab Anal; 2021 Jun; 35(6):e23774. PubMed ID: 33951240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma uric acid level indicates tubular interstitial leisions at early stage of IgA nephropathy.
    Zhou J; Chen Y; Liu Y; Shi S; Li X; Wang S; Zhang H
    BMC Nephrol; 2014 Jan; 15():11. PubMed ID: 24423013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The predictive value of free thyroxine combined with tubular atrophy/interstitial fibrosis for poor prognosis in patients with IgA nephropathy.
    Yang B; Zhou W; Cui L; Tian L; Ni Y; Yang M; Yang Y
    Front Endocrinol (Lausanne); 2024; 15():1372824. PubMed ID: 38808109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating TNF receptors 1 and 2 are associated with the severity of renal interstitial fibrosis in IgA nephropathy.
    Sonoda Y; Gohda T; Suzuki Y; Omote K; Ishizaka M; Matsuoka J; Tomino Y
    PLoS One; 2015; 10(4):e0122212. PubMed ID: 25860248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of time-averaged serum uric acid level with clinicopathological information and long-term outcomes in patients with IgA nephropathy.
    Weng M; Fu B; Zhuo Y; Lin J; Zou Z; Chen Y; Cui J; Li G; Chen C; Xu Y; Jiang D; Wan J
    PeerJ; 2024; 12():e17266. PubMed ID: 38650643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and prognostic significance of C1q deposition in IgAN patients-a retrospective study.
    Tian S; Yang X; Luo J; Guo H
    Int Immunopharmacol; 2020 Nov; 88():106896. PubMed ID: 33182045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uric Acid as a Predictor of Immunoglobulin A Nephropathy Progression: A Cohort Study of 1965 Cases.
    Zhu B; Yu DR; Lv JC; Lin Y; Li Q; Yin JZ; Du YY; Tang XL; Mao LC; Li QF; Sun Y; Liu L; Li XF; Fei D; Wei XY; Zhu CF; Cheng XX; Chen HY; Wang YJ
    Am J Nephrol; 2018; 48(2):127-136. PubMed ID: 30110674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum levels of tumor necrosis factor alpha in patients with IgA nephropathy are closely associated with disease severity.
    Li G; Wu W; Zhang X; Huang Y; Wen Y; Li X; Gao R
    BMC Nephrol; 2018 Nov; 19(1):326. PubMed ID: 30428849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma Homocysteine as a Potential Marker of Early Renal Function Decline in IgA Nephropathy.
    Wang YN; Xia H; Song ZR; Zhou XJ; Zhang H
    Front Med (Lausanne); 2022; 9():812552. PubMed ID: 35321472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic redox biomarkers and their relationship to prognostic risk markers in autosomal dominant polycystic kidney disease and IgA nephropathy.
    Tariq A; Mansoor MA; Marti HP; Jonsson G; Slettan A; Weeraman P; Apeland T
    Clin Biochem; 2018 Jun; 56():33-40. PubMed ID: 29655960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a diagnostic nomogram to evaluate tubular atrophy/interstitial fibrosis of IgA nephropathy.
    Gan Y; Cai Y; Li J; Wu J; Zhang R; Han Q; Li W; Yang Q
    Int J Med Sci; 2024; 21(4):674-680. PubMed ID: 38464822
    [No Abstract]   [Full Text] [Related]  

  • 14. A pilot and comparative study between pathological and serological levels of immunoglobulin and complement among three kinds of primary glomerulonephritis.
    Dong J; Peng T; Gao J; Jia X; Yan G; Wang Y
    BMC Immunol; 2018 Jun; 19(1):18. PubMed ID: 29925312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of endocapillary hypercellularity in IgA nephropathy patients with no immunosuppression.
    Chakera A; MacEwen C; Bellur SS; Chompuk LO; Lunn D; Roberts ISD
    J Nephrol; 2016 Jun; 29(3):367-375. PubMed ID: 26318019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of Oxford classification, and overexpression of transforming growth factor-β1 and immunoglobulins in immunoglobulin A nephropathy: correlation with World Health Organization classification of immunoglobulin A nephropathy in a Chinese patient cohort.
    Meng H; Zhang L; E X; Ye F; Li H; Han C; Yamakawa M; Jin X
    Transl Res; 2014 Jan; 163(1):8-18. PubMed ID: 23891568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperuricemia and hypertriglyceridemia indicate tubular atrophy/interstitial fibrosis in patients with IgA nephropathy and membranous nephropathy.
    Liu B; Zhao L; Yang Q; Zha D; Si X
    Int Urol Nephrol; 2021 Nov; 53(11):2321-2332. PubMed ID: 33895976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex disparities in IgA nephropathy: a retrospective study in Chinese patients.
    Wen D; Tang Y; Tan L; Tan J; Chen D; Zhang Y; Qin W
    Int Urol Nephrol; 2021 Feb; 53(2):315-323. PubMed ID: 32944891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The correlation analysis between the Oxford classification of Chinese IgA nephropathy children and renal outcome - a retrospective cohort study.
    Wu H; Xia Z; Gao C; Zhang P; Yang X; Wang R; Wang M; Peng Y
    BMC Nephrol; 2020 Jul; 21(1):247. PubMed ID: 32611399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High Neutrophil-To-Lymphocyte Ratio Is an Independent Risk Factor for End Stage Renal Diseases in IgA Nephropathy.
    Wang S; Dong L; Pei G; Jiang Z; Qin A; Tan J; Tang Y; Qin W
    Front Immunol; 2021; 12():700224. PubMed ID: 34456912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.